Finerenone after heart procedure to lower atrial fibrillation return
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether taking finerenone after a heart procedure to fix irregular heartbeat can help prevent atrial fibrillation from coming back. It's for people having their first such procedure and aims to improve long-term heart rhythm health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have atrial fibrillation and are scheduled for your first catheter ablation (a procedure to correct irregular heartbeats).
- Your kidney function is adequate (eGFR of 25 or higher).
- Your blood potassium level is 5.0 or lower.
- You have not had this type of heart procedure before.
- You are not currently taking other medications in the same class as finerenone (mineralocorticoid receptor antagonists).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether finerenone, a medication that may help the heart work better, can improve electrical stability in people with a certain type of heart failure (HFpEF). It aims to reduce irregular heart rhythms and improve overall heart health.
This trial tests a medication called finerenone to see if it helps people hospitalized for heart failure live longer and have fewer heart-related problems. It may be an option for those with a certain type of heart failure where the heart's pumping strength is mildly reduced or normal.
This trial tests a new medicine called finerenone to see if it can reduce heart scarring and improve heart function in people with a certain type of heart failure (preserved ejection fraction). If you qualify, you may help researchers learn if this treatment can help you feel better and stay out of the hospital.
This study tests whether finerenone, a new type of drug, can help people with heart failure who cannot take standard steroid-based MRAs (a kind of heart medication) because of side effects or other reasons. It aims to see if it improves symptoms and is safe for you.
This study tests if the drug finerenone helps people with heart failure who had a heart valve replacement (TAVI) for severe aortic stenosis. The goal is to see if it improves heart function and outcomes.
This study tests whether a medicine called eplerenone can help prevent atrial fibrillation from coming back in people who also have structural heart disease (changes in the heart's structure). If you have had episodes of irregular heartbeat that stopped, this drug might lower the chance of them returning.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.